Skip to content
Sign in

BME · NYSE · Closed-end fund

BlackRock Health Sciences Trust (BME) Price, Holdings & Fees

$462.99−0.56%−$2.61End-of-day price as of Oct 9, 2026

BlackRock Health Sciences Trust (BME) closed at $462.99 on Oct 9, 2026, down 0.56% from the previous close of $465.60.

Share price, past year

1Y +52.77%

52-week range $296.01 – $476.82. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$462.99
Sep 30, 2026$474.19
Aug 31, 2026$460.33
Jul 31, 2026$442.97
Jun 30, 2026$396.29
May 29, 2026$387.43
Apr 30, 2026$371.73
Mar 31, 2026$360.88
Feb 27, 2026$358.96
Jan 30, 2026$321.59
Dec 31, 2025$327.48
Nov 28, 2025$308.88
Oct 31, 2025$318.02

Key statistics

Expense ratio
—
Net assets
$571.5M
as of Jun 30, 2026
Holdings
156
as of Jun 30, 2026
52-week range
$296.01 – $476.82

Holdings

BlackRock Health Sciences Trust held 156 investments worth $571.47M as of Jun 30, 2026. Its largest holding was Eli Lilly & Co, at 12.46% of the fund.

BlackRock Health Sciences Trust largest holdings by share of net assets
#Holding% of fundValue
1Eli Lilly & Co12.46%$71.22M
2Johnson & Johnson7.80%$44.60M
3UnitedHealth Group Inc6.12%$34.98M
4Merck & Co Inc5.23%$29.89M
5AbbVie Inc5.07%$28.96M
6Gilead Sciences Inc3.68%$21.06M
7Amgen Inc3.37%$19.27M
8BlackRock Liquidity Funds3.33%$19.05M
9Thermo Fisher Scientific Inc2.97%$16.96M
10Vertex Pharmaceuticals Inc2.78%$15.89M
11Edwards Lifesciences Corp2.37%$13.56M
12Danaher Corp1.92%$10.97M
13Abbott Laboratories1.90%$10.85M
14Elevance Health Inc1.86%$10.64M
15Pfizer Inc1.49%$8.53M
16Argenx SE1.31%$7.48M
17Boston Scientific Corp1.30%$7.42M
18Biogen Inc1.20%$6.89M
19Teva Pharmaceutical Industries Ltd1.16%$6.62M
20Intuitive Surgical Inc1.15%$6.54M
21Stryker Corp1.10%$6.28M
22Revolution Medicines Inc1.05%$6.01M
23Moderna Inc1.00%$5.70M
24Waters Corp0.99%$5.65M
25Cytokinetics Inc0.89%$5.06M

Top 25 of 156 holdings, as of Jun 30, 2026. Percentages are of the fund's net assets.

What the fund owns

BlackRock Health Sciences Trust holdings by asset type
Asset type% of fund
Stocks96.48%
Cash and short-term investments3.66%
Preferred stock0.04%
Other0.01%
BlackRock Health Sciences Trust holdings by country, largest 10
Country% of fund
United States94.20%
Switzerland1.33%
Netherlands1.31%
Israel1.16%
United Kingdom0.86%
Bermuda0.34%
Belgium0.25%
Japan0.17%
Canada0.16%
Jersey0.13%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to Jun 30, 2026, BlackRock Health Sciences Trust's total return was +9.39%, as reported to the SEC.

BlackRock Health Sciences Trust monthly total returns
MonthTotal return
Jun 30, 2026+7.05%
May 31, 2026+2.73%
Apr 30, 2026−0.53%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
BlackRock Health Sciences Trust
Ticker
BME
Exchange
NYSE
Fund type
Closed-end fund
SEC CIK
0001314966
Fractional shares
Yes

Recent SEC filings

Frequently asked questions

What is BME's price?

BlackRock Health Sciences Trust (BME) closed at $462.99 on Oct 9, 2026, down 0.56% from the previous close of $465.60.

What does BME hold?

BlackRock Health Sciences Trust held 156 investments worth $571.47M as of Jun 30, 2026. Its largest holding was Eli Lilly & Co, at 12.46% of the fund. Its five largest holdings were Eli Lilly & Co, Johnson & Johnson, UnitedHealth Group Inc, Merck & Co Inc, AbbVie Inc.

How has BME performed?

Over the 3 months to Jun 30, 2026, BlackRock Health Sciences Trust's total return was +9.39%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jun 30, 2026 (filed Aug 25, 2026). Prices are generated sample data for development. Data sources and disclosures